Guangzhou Yibang Pharmaceutical Technology Co., Ltd., established in 2006, is an innovative enterprise specializing in the development, production, and research of services in the pharmaceutical and chemical fields. Its business scope includes: R&D and technology transfer of new drug technologies, development and production of novel anti-tumor drug intermediates, synthesis and production of various chemical intermediates, scientific research services in the chemical and biological fields, as well as the introduction, incubation, and industrialization of pharmaceutical biotechnology achievements. Currently, it collaborates with major domestic pharmaceutical manufacturers.